Antioxidant Effects of Resveratrol in Intervertebral Disk

Intervertebral disk (IVD) degeneration (IVDD) can cause various spinal degenerative diseases. Cumulative evidence has indicated that IVDD can result from inflammation, apoptosis, autophagy, biomechanical changes and other factors. Currently, lack of conservative treatment for degenerative spinal dis...

Full description

Bibliographic Details
Published in:	Journal of Investigative Surgery
Main Authors:	Yachong Huo, Dalong Yang, Kaitao Lai, Ji Tu, Yibo Zhu, Wenyuan Ding, Sidong Yang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-05-01
Subjects:	resveratrol intervertebral disk degeneration antioxidant oxidative stress reactive oxygen species
Online Access:	http://dx.doi.org/10.1080/08941939.2021.1988771

Similar Items

Biomimetic Microstructural Materials for Intervertebral Disk Degeneration Repair
by: Ang Li, et al.
Published: (2025-01-01)

Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies
by: Yiming Dou, et al.
Published: (2021-07-01)

Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration
by: Yanbing Gao, et al.
Published: (2023-12-01)

Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review
by: Ming‐yang Liu, et al.
Published: (2022-12-01)

Association Between VDR FokI Polymorphism and Intervertebral Disk Degeneration
by: Jian Zhao, et al.
Published: (2015-12-01)

A new target for treating intervertebral disk degeneration: gut microbes
by: Kaizhong Wang, et al.
Published: (2024-11-01)

Optimization of Spinal Anesthesia in Surgery of Intervertebral Disks
by: V. I. Gorbachev, et al.
Published: (2006-12-01)

Decoding Macrophage Subtypes to Engineer Modulating Hydrogels for the Alleviation of Intervertebral Disk Degeneration
by: Da‐Wang Zhao, et al.
Published: (2024-01-01)

Apigetrin alleviates intervertebral disk degeneration by regulating nucleus pulposus cell autophagy
by: Tao Xu, et al.
Published: (2024-06-01)

Characterization and modulation of the pro‐inflammatory effects of immune cells in the canine intervertebral disk
by: Mary K. Heimann, et al.
Published: (2024-06-01)

MiR-206 improves intervertebral disk degeneration by targeting GJA1
by: Peng Zhou, et al.
Published: (2022-03-01)

The Role of Microvascular Variations in the Process of Intervertebral Disk Degeneration and Its Regulatory Mechanisms: A Literature Review
by: Si‐Ping Zhang, et al.
Published: (2024-11-01)

Changes in the composition of the fecal metabolome and gut microbiota contribute to intervertebral disk degeneration in a rabbit model
by: Shuai Cheng, et al.
Published: (2024-01-01)

Obesity Mediates Apoptosis and Extracellular Matrix Metabolic Imbalances via MAPK Pathway Activation in Intervertebral Disk Degeneration
by: Xuyang Zhang, et al.
Published: (2019-10-01)

The role of ferroptosis in intervertebral disc degeneration
by: Chunyang Fan, et al.
Published: (2023-07-01)

Resveratrol Combined with 17β-Estradiol Prevents IL-1β Induced Apoptosis in Human Nucleus Pulposus Via The PI3K/AKT/Mtor and PI3K/AKT/GSK-3β Pathway
by: Xiaoliang Bai, et al.
Published: (2021-07-01)

Chrysin attenuates intervertebral disk degeneration via dual inhibition of matrix metalloproteinases and senescence: integrated network pharmacology, molecular docking, and experimental validation
by: Zeyu Pang, et al.
Published: (2025-05-01)

Innovative strategies in combating intervertebral disc degeneration: pathological mechanisms and biomaterial advancements
by: Long Ma, et al.
Published: (2025-08-01)

Mitochondrial Dysfunction in Oxidative Stress‐Mediated Intervertebral Disc Degeneration
by: Dian‐Kai Wang, et al.
Published: (2022-08-01)

Therapeutic effect and mechanism of Yougui Wan in rats with intervertebral disk degeneration
by: She Ma, et al.
Published: (2024-01-01)

Unveiling the role of CXCL8/CXCR2 in intervertebral disc degeneration: A path to promising therapeutic strategies
by: Pengfei Xue, et al.
Published: (2024-11-01)

Nano-Drug Delivery System Targeting the Oxidative Stress Microenvironment: A Prospective Strategy for Intervertebral Disc Degeneration Treatment
by: Wang Y, et al.
Published: (2025-09-01)

Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc
by: Changli Zhang, et al.
Published: (2025-07-01)

Facing Back Pain with Wine and Physical Activity
by: Silvia Ravalli, et al.
Published: (2022-05-01)

Beneficial Effects of Resveratrol on Testicular Functions: Focus on Its Antioxidant Properties
by: Adele Chimento, et al.
Published: (2025-07-01)

Role of oxidative stress in mitochondrial dysfunction and their implications in intervertebral disc degeneration: Mechanisms and therapeutic strategies
by: Hao Zhou, et al.
Published: (2024-11-01)

Antioxidant effects of resveratrol in granulocytes from multiple sclerosis patients
by: Pedro Henrique Villar-Delfino, et al.
Published: (2024-08-01)

Causal effects of skin microbiota on intervertebral disk degeneration, low back pain and sciatica: a two-sample Mendelian randomization study
by: Yuchao Jia, et al.
Published: (2024-08-01)

Macrophage Changes and High‐Throughput Sequencing in Aging Mouse Intervertebral Disks
by: Wei Wang, et al.
Published: (2025-06-01)

Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration
by: Junyuan Sun, et al.
Published: (2023-05-01)

Intervertebral disk regeneration in a rat model by allopurinol–loaded chitosan/alginate hydrogel
by: Linhui Ye, et al.
Published: (2023-07-01)

The MnO<sub>2</sub>/GelMA Composite Hydrogels Improve the ROS Microenvironment of Annulus Fibrosus Cells by Promoting the Antioxidant and Autophagy through the SIRT1/NRF2 Pathway
by: Bohan Xu, et al.
Published: (2024-05-01)

tsRNA-04002 alleviates intervertebral disk degeneration by targeting PRKCA to inhibit apoptosis of nucleus pulposus cells
by: Jie Pan, et al.
Published: (2023-06-01)

Lipid metabolic disorders and their impact on cartilage endplate and nucleus pulposus function in intervertebral disk degeneration
by: Ruixia Wu, et al.
Published: (2025-03-01)

3‐D Sustained‐Release Culture Carrier Alleviates Rat Intervertebral Disc Degeneration by Targeting STING in Transplanted Skeletal Stem Cells
by: Liwen Luo, et al.
Published: (2025-04-01)

Nucleotide polymorphism-based study utilizes human plasma liposomes to discover potential therapeutic targets for intervertebral disc disease
by: Ding-Qiang Chen, et al.
Published: (2024-08-01)

Effects of Resveratrol on Vascular Function in Retinal Ischemia-Reperfusion Injury
by: Panagiotis Chronopoulos, et al.
Published: (2023-04-01)

Oral administration of resveratrol reduces oxidative stress generated in the hippocampus of Wistar rats in response to consumption of ethanol
by: Addí Rhode Navarro-Cruz, et al.
Published: (2024-01-01)

The role of micronutrients and serum metabolites in intervertebral disk degeneration: insights from a Mendelian randomization study and mediation analysis
by: Nizhou Jiang, et al.
Published: (2024-10-01)

Exosomes derived from human urine–derived stem cells ameliorate IL-1β-induced intervertebral disk degeneration
by: Guang Qian, et al.
Published: (2024-07-01)